Caplacizumab Therapy in Immune Thrombotic Thrombocytopenic Purpura

被引：0

作者：

Reti, Marienn ^{[1
]}

Sinkovits, Gyorgy ^{[2
]}

Varkonyi, Andrea ^{[1
]}

Kiraly, Agnes ^{[1
]}

Farkas, Zita ^{[1
]}

Bogsch, Luca ^{[1
]}

Icleanu, Andreea-Adela ^{[2
]}

Masszi, Tamas ^{[2
]}

Valyi-Nagy, Istvan ^{[1
]}

Prohaszka, Zoltan ^{[2
]}

Remenyi, Peter Pal ^{[1
]}

机构：

[1] Cent Hosp Southern Pest, Natl Inst Hematol & Infect Dis, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary

[2] Semmelweis Univ, Eotvos Lorand Res Network, Off Supported Res Grp, Dept Internal Med & Hematol, Budapest, Hungary

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186633

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Cost-Effectiveness of Caplacizumab in the Warranty Program in Immune Thrombotic Thrombocytopenic Purpura in the USA [J].

Sullivan, Sean D. ;

Chaturvedi, Shruti ;

Gautam, Preety ;

Arnaud, Alix .

BLOOD, 2023, 142

[42] A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura [J].

Gomez-Segui, Ines ;

Fernandez-Zarzoso, Miguel ;

de la Rubia, Javier .

EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (11) :1153-1164

[43] Thrombotic thrombocytopenic purpura in caplacizumab era-An individualized approach [J].

Sarode, Ravi .

TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (02)

[44] Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura [J].

Elverdi, Tugrul ;

Eskazan, Ahmet Emre .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :1251-1258

[45] Characterization of Bleeding in Thrombotic Thrombocytopenic Purpura Treated without Caplacizumab [J].

Mahmoud, Amir ;

Shah, Purva ;

Eltaher, Basant ;

Mostafa, Mariam A. ;

Abdelhay, Ali ;

Abou-Ismail, Mouhamed Yazan ;

Chaturvedi, Shruti .

BLOOD, 2024, 144 :2619-2619

[46] Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use [J].

Hannah A. Blair ;

Katherine A. Lyseng-Williamson .

Drugs & Therapy Perspectives, 2019, 35 :263-270

[47] Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial) [J].

Estcourt, L. J. .

TRANSFUSION MEDICINE, 2019, 29 (03) :146-148

[48] ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy [J].

Mingot-Castellano, Maria-Eva ;

Garcia-Candel, Faustino ;

Martinez-Nieto, Jorge ;

Garcia-Arroba, Jose ;

de la Rubia-Comos, Javier ;

Gomez-Segui, Ines ;

Paciello-Coronel, Maria-Liz ;

Valcarcel-Ferreiras, David ;

Jimenez, Moraima ;

Cid, Joan ;

Lozano, Miquel ;

Garcia-Gala, Jose-Maria ;

Angos-Vazquez, Sonia ;

Vara-Pampliega, Miriam ;

Guerra-Dominguez, Luisa ;

Avila-Idrobo, Laura-Francisca ;

Oliva-Hernandez, Ana ;

Zalba-Marcos, Saioa ;

Tallon-Ruiz, Inmaculada ;

Ortega-Sanchez, Sandra ;

Goterris-Viciedo, Rosa ;

Moreno-Jimenez, Gemma ;

Dominguez-Acosta, Lourdes ;

Araiz-Ramirez, Maria ;

Hernandez-Mateos, Luis ;

Flores-Ballesteros, Elena ;

del Rio-Garma, Julio ;

Pascual-Izquierdo, Cristina .

BLOOD, 2024, 143 (18) :1807-1815

[49] Caplacizumab Speeds Resolution of Acute Episodes of Thrombotic Thrombocytopenic Purpura [J].

不详 .

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) :194-194

[50] Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use [J].

Blair, Hannah A. ;

Lyseng-Williamson, Katherine A. .

DRUGS & THERAPY PERSPECTIVES, 2019, 35 (06) :263-270

← 1 2 3 4 5 →